A phase II trial evaluating irinotecan with 5-fluorouracil plus leucovorin [folinic acid] in patients with relapsed/refractory upper gastrointestinal tumours.
Phase of Trial: Phase II
Latest Information Update: 19 Sep 2012
At a glance
- Drugs Fluorouracil; Folinic acid; Irinotecan
- Indications Gastric cancer; Pancreatic cancer
- Focus Therapeutic Use
- 12 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Nov 2005 New trial record.